CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Help us provide hope to people living with AMD

Your gift will help research into age‑related macular degeneration, giving hope for a brighter world for those living with AMD-related vision loss.

Video

Find out more about how glaucoma researchers at CERA are leading the way towards new treatments in the recording of our World Glaucoma Day Community Forum.

Eye Conditions

Our Understanding age-related macular degeneration guide gives you an introduction to the disease and CERA's world-class research.

CAREERS AND STUDY

Explore research projects currently open for expressions of interest from Masters, Doctorate or PhD students.

Donate to CERA

With your support, there’s hope in sight.

Your gift will contribute to our world-leading vision research, making a real difference to people affected by vision loss and blindness.

Donate now

Take part in research

We conduct world-leading clinical trials for a range of eye conditions.

Learn more about taking part in clinical trials for conditions like age-related macular degeneration, glaucoma, diabetic retinopathy and more.

Learn more

Latest News


Research

15 May 2024

Thanks to tireless research, it’s hoped people will be diagnosed with ‘dry’ age-related macular degeneration earlier and have clear pathways to treatments.

Research

09 May 2024

A new project is using cutting-edge DNA sequencing technology to find the genetic cause of not-yet-understood inherited retinal diseases.

Stories

09 May 2024

On International Nurses Day, we celebrate our Lions Eye Donation Service coordinators out in the field and in the lab – working to protect sight for current and future generations.

Research

09 May 2024

Dr Sandy Hung is a Research Fellow in CERA’s Clinical Genetics team working to develop gene delivery technology to improve current treatments for rare eye diseases – a leading cause of blindness in working-age Australians.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals